Quick Answer
ABVC BIOPHARMA, INC. reported Net Income of -$7.91 million for fiscal year 2025.
ABVC BIOPHARMA, INC. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$7.91M | -61.3% |
| 2024 | -$4.90M | +37.0% |
| 2023 | -$7.79M | +52.6% |
| 2022 | -$16.42M | -27.9% |
| 2021 | -$12.84M | -21.2% |
| 2020 | -$10.59M | -169.3% |
| 2019 | -$3.93M | +35.1% |
| 2018 | -$6.06M | -42.9% |
| 2017 | -$4.24M | -4.2% |
| 2017 | -$4.07M | +63.0% |
| 2016 | -$11.01M | -33999.9% |
| 2015 | -$32.3K | -38.9% |
| 2014 | -$23.2K | +89.7% |
| 2013 | -$226.4K | +78.8% |
| 2012 | -$1.07M | +12.2% |
| 2011 | -$1.22M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.25M | -215.8% | +44.8% |
| June 30, 2025 | -$2.26M | -139.5% | -168.0% |
| March 31, 2025 | -$842.1K | +70.3% | -113.3% |
| September 30, 2024 | -$394.8K | +88.1% | +58.1% |
| June 30, 2024 | -$942.3K | +58.4% | +66.8% |
| March 31, 2024 | -$2.83M | -55.4% | +14.6% |
| September 30, 2023 | -$3.32M | +10.5% | -46.6% |
| June 30, 2023 | -$2.26M | -21.8% | -24.1% |
- ABVC BIOPHARMA, INC. showed a decrease of -61.3% in Net Income compared to the prior fiscal year.
- Over the 2011–2025 period, ABVC BIOPHARMA, INC.’s net income has declined by 549.0% (from -$1.22 million to -$7.91 million).
- The most recent figure is from ABVC BIOPHARMA, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: